Teething (Liddell Laboratories, Inc.)


Welcome to the PulseAid listing for the Teething drug offered from Liddell Laboratories, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Liddell Laboratories, Inc.
NON-PROPRIETARY NAME: Aconitum napellus, Belladonna, Borax, Calcarea phosphorica, Chamomilla, Kali phosphoricum, Magnesia phosphorica, Nitricum acidum, Staphysagria,
SUBSTANCE NAME: ACONITUM NAPELLUS; ATROPA BELLADONNA; SODIUM BORATE; TRIBASIC CALCIUM PHOSPHATE; CHAMOMILE; POTASSIUM PHOSPHATE, DIBASIC; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; NITRIC ACID; DELPHINIUM STAPHISAGRIA
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2011-01-25
END MARKETING DATE: 0000-00-00


Teething HUMAN OTC DRUG Details:

Item DescriptionTeething from Liddell Laboratories, Inc.
LABELER NAME: Liddell Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 30; 30; 30; 8; 3; 6; 8; 30; 9([hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL)
START MARKETING DATE: 2011-01-25
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50845-0122_7cf9d96e-11ec-4bcf-8603-b11a88df1531
PRODUCT NDC: 50845-0122
APPLICATION NUMBER:

Other ACONITUM NAPELLUS; ATROPA BELLADONNA; SODIUM BORATE; TRIBASIC CALCIUM PHOSPHATE; CHAMOMILE; POTASSIUM PHOSPHATE, DIBASIC; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; NITRIC ACID; DELPHINIUM STAPHISAGRIA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Liddell Laboratories, Inc.Teething